QualityStocks Stock Newsletters Archives - Page 9 of 1818

WednesdaySep 12, 2012 2:45 pm

National Graphite Corp. (NGRC) Completes Electro-Magnetic Survey at Chedic/Voltaire Graphite Property in Nevada

National Graphite, the domestic mineral development firm focused on graphite and precious metal projects in North America, was pleased to report today that the StrataGem Electro-Magnetic Survey on the company's flagship graphite site in northwestern Nevada (100% interest via the agreement with GeoXplor Corp. from April 24, 2012), the 400-acre Chedic/Voltaire property in Carson City, has been successfully completed. Given the lack of natural graphite production here in the U.S. and China's dominant role with 75% of global output (with India in second ahead of export markets like Brazil or Canada), this strategically critical resource demands domestic development and NGRC…

WednesdaySep 12, 2012 1:30 pm

Transcept Pharmaceuticals, Inc. (TSPT) Finishes Patient Enrollment in Phase 2 Trial of TO-2061

Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. One such product in the company's pipeline is TO-2061, a drug to be used in patients with obsessive-compulsive disorder. The company announced today that it has completed patient enrollment in its Phase 2 clinical trial evaluating TO-2061 which is added as an adjunctive therapy for patients with obsessive-compulsive order (OCD). These patients have not responded adequately to standard first-line treatment with a currently approved OCD medication. These medications include the selective serotonin re-uptake inhibitors…

WednesdaySep 12, 2012 1:12 pm

Altairnano, Inc. (ALTI) and Shenhua Science & Technology Sign Memorandum of Understanding

It was recently announced that an agreement was signed by three parties to develop, deploy, and promote industrial applications of lithium titanate-based energy storage systems in China. Altairnano, Shenhua Science & Technology (Shenhua S&T) and its research affiliate, and the National Institute of Clean and Low-carbon Energy (NICE) signed a memorandum of understanding (MOU) that calls for the launch of a pilot project to deploy and test an Altairnano ALTI-ESS Advantage System at one of Shenhua's wind farms in China. As part of the MOU, a joint working group comprised of members of all three organizations was formed to define…

WednesdaySep 12, 2012 12:11 pm

Terra Tech Corp. (TRTC) Spammed Aggressively

We have observed emails spamming Terra Tech Corp. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics page, visit www.basics.qualitystocks.net Let us hear your thoughts below:

WednesdaySep 12, 2012 11:21 am

SFDA Approval Granted for Dehaier Medical Ltd. (DHRM) DHR-CPAP-C5 Device for Treating Sleep Apnea

Dehaier Medical Systems announced that it has obtained State Food and Drug Administration approval for DHR-CPAP-C5, one of the company’s primary proprietary homecare medical devices. The validity period for the SFDA approval is four years. Continuous positive airway pressure (CPAP) has become the first-line treatment for obstructive sleep apnea syndrome (OSAS), as well as for some forms of central sleep apnea. CPAP works by creating a pneumatic splint for the upper airway. Pressurized air is sent through air tubing and a mask (generally a nose mask) and through the nose to the upper airway by means of a flow generator.…

WednesdaySep 12, 2012 8:53 am

QualityStocks is on the Apple App Store!

Do you have an iPhone, iPad, or iPod Touch? If so, good news! You can access the latest micro-cap and small-cap news, in-depth articles on emerging growth companies, our currently featured companies, real-time Twitter updates and Facebook posts, and new “Ones to Watch!” It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. Our team works very hard to bring the same high-quality content you expect from QualityStocks to your mobile devices. To check out the new app, search for “QualityStocks” on your device or visit http://dtg.fm/app Let us hear…

TuesdaySep 11, 2012 4:21 pm

Cytomedix, Inc. (CMXI) to Highlight FDA-Cleared AutoloGel System at Symposium on Advanced Wound Care Fall 2012

Cytomedix, a developer of advanced autologous adult stem cell technologies for wound and tissue repair, will display its AutoloGel™ System in three poster presentations at the upcoming Symposium on Advanced Wound Care Fall 2012 (Sept 12-14) at the Baltimore Convention Center. Cytomedix will also host a booth at the symposium where attendees and clinicians can learn more how AutoloGel can produce autologous platelet rich plasma (PRP) gel for use in wound management. The system is the only PRP device cleared by the U.S. Food and Drug Administration (FDA) for this application. Presenting AutoloGel at the SAWC Fall 2012 provides exposure…

TuesdaySep 11, 2012 2:12 pm

Lithium Corp. (LTUM) Applies for Canadian National Stock Exchange Listing Amid Consolidating Industry Dynamics

Lithium Corporation, the junior mineral development firm focused on its primary suite of three wholly-owned prospects in Nevada, each with a defined lithium/brine surface target and quantifiable lithium anomalies, was happy to report successful execution today of a key step towards listing on the Canadian National Stock Exchange (CNSX) via the filing of an application with the BC Securities Commission (BCSC). LTUM has also filed a Preliminary Long Form Prospectus with the BCSC in support of this move, which includes a 43-101 report (James Chapman, P. Geo) on the company's flagship Fish Lake Valley prospect that should help solidify the…

TuesdaySep 11, 2012 1:47 pm

Bacterin International Holdings, Inc. (BONE) Reports Positive First Clinical Results for OsteoSponge SC Product

Bacterin International Holdings develops, manufactures, and markets biologics products, such as bone graft material and antimicrobial coatings, worldwide. The company's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair, and dermal growth. These products are used in a wide variety of surgeries. The company announced today that the first clinical results using the OsteoSponge SC product for regeneration of subchondral bone in complex lesions of the talus involving advanced subchondral bone damage have been published in the peer-reviewed journal, Foot & Ankle Specialist. The article reported on six…

TuesdaySep 11, 2012 9:50 am

eMagin Corp. (EMAN) Increases Production Capacity Through Automation

eMagin has achieved automation of its newest SNU OLED deposition machine, increasing capacity and improving its ability to manufacture OLED microdisplays. Testing of the displays produced by the new automated system will be completed in mid-September; after which, the displays will be ready for shipping. eMagin is focused on producing OLED microdisplays, and is proficient in OLED microdisplay tech and mobile display systems. The company produces microdisplays equipped with magnification systems that allow portable, low-powered devices to achieve display imagery comparable to larger screen computers and televisions. eMagin produces displays for use in military, industrial, medical, and consumer markets. eMagin's…

Site Search

Company Search

Category: QualityStocks Stock Newsletters